Transcription of Nonalcoholic fatty liver disease (NAFLD) Nonalcoholic ...
{{id}} {{{paragraph}}}
Nonalcoholic fatty liver disease ( nafld ) Nonalcoholic steatohepatitis (NASH) Dawn McDowell Torres, MD Chief, Gastroenterology Walter Reed National Military Medical Center Disclosure of Financial Relationships Dawn M. Torres, MD Has disclosed relationships with an entity producing, marketing, re-selling, or distributing health care goods or services consumed by, or used on, patients. Research Grants/Contracts Abbvie, Galectin, Gilead, Intercept, Conatus Speaker s Bureau None Objectives Describe the primary etiologies of chronic hepatitis today and predictions for the future face of liver disease Understand the criteria required for the diagnosis of nafld and NASH Outline the current available treatments for nafld and NASH QUESTION What is the most common chronic liver disease in the US?
Nonalcoholic fatty liver disease (NAFLD) Nonalcoholic steatohepatitis (NASH) Dawn McDowell Torres, MD Chief, Gastroenterology Walter Reed National Military Medical Center
Domain:
Source:
Link to this page:
Please notify us if you found a problem with this document:
{{id}} {{{paragraph}}}
Non-Alcoholic Fatty Liver Disease NAFLD, Nonalcoholic fatty, Disease, Nonalcoholic fatty liver disease, Liver, Nonalcoholic Fatty Liver Disease and Nonalcoholic, Fatty Liver, Liver disease, Non-Alcoholic, Nonalcoholic fatty liver disease NAFLD, Nonalcoholic fatty liver disease and, Nonalcoholic, EASO Clinical Practice Guidelines for the, Non-alcoholic fatty liver disease, Nonalcoholic steatohepatitis